Powered by

Acerus Pharmaceuticals drops 3.8% - trailing 89% of stocks February 28, 2017 17:00 EST

Feb 28, 2017 - News Bites Canadian Markets


Acerus Pharmaceuticals Corporation (TSX:ASP), Canada's 6th largest Drug manufacturers company by market cap, has dropped 0.50c (3.8%) from its last trading session of February 27 to close at 12.50c. Compared with the S&P/TSX 60 Index which fell 4.8 points (0.5%) in the day, the relative price change was -3.3%. The volume was 0.2 times the average daily trading volume of 489,022 shares. In the Canadian market of 1,949 stocks and 84 units traded today, the stock h

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox